FDA Investigator Sherry M Nisson
Sherry M Nisson has conducted inspections on 203 sites in 1 countries as of 09 Dec 2015. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
203
Last Inspection Date:
09 Dec 2015
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Sherry M Nisson:
Alan R Condon,
Aldo J Quintana,
Alice C Silva,
Alois P Provost,
Anna M Brannen,
Anthony N Onianwa,
Anthony W Thomas,
Ashley M Whitehurst,
Carla C Tuite,
Constance Desimone,
Courtney N Long,
David J Feria,
David P Vanhouten,
Diane M Prince,
Dorothy W Lee,
Elizabeth B Griffin,
Ellen P Madigan,
Eric C Schmitt,
Garry H Stewart,
Gary J Hagan,
James P Finn,
John A Hamilton, III,
John J Thibodeau,
John S Hartford,
Jonah S Ufferfilge,
Jorge E Martinez,
Justine M Corson,
Karen Mcnabb Noon,
Karen N Archdeacon,
Kathleen E Mcafoose,
Kathleen M Curry,
Kent A Conforti,
Kip J Hanks,
La Tasham Gunter,
Laurie A Haxel,
LCDR Debra Emerson,
Leena Thomas,
Lequita M Mayhew,
Lorayne A Mcguinness,
LTJG Bradley E Benasutti,
Marcia M Laughrey,
Margaret E Walsh,
Marlene L Davis,
Mary E Baker Brown,
Mary T Carden,
Maura Rooney,
Melinda K Plaisier,
Monique C Lo,
Nisha C Patel,
Pamela L Ogonowski,
Paraluman S Leonin,
Patricia A Clark,
Robert O'brian,
Rory K Geyer,
Sandra P White,
Stephen C Smith,
Sylvia A Craven,
Tamara M Kays,
Troy R Petrillo
Sherry M Nisson's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2003 | EIR | Rhode Island Blood Center, A Division of New York Blood Center, Inc. - EIR, 2003-06-19 |
May, 2000 | EIR | ARC/National Testing Lab - EIR, 2000-05-26 |
January, 2003 | EIR | The American National Red Cross - EIR, 2003-01-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more